Evidence map›Paper›PMID 39970002›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2025

Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney Disease.

Kristen L Nowak, Timothy P Copeland, Elaine Ku, Mark J Sarnak, Berenice Gitomer, Kaleab Z Abebe, Arlene Chapman, Ronald Perrone, Frederic F Rahbari-Oskoui, Theodore Steinman and 2 more

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Renal blood flow and progression to kidney failure in ADPKD.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Observational
  3. Review
  4. KDIGO 2025 ADPKD guideline through pediatric eyes.Pediatric nephrology (Berlin, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kristen L NowakDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0001-9364-3256
Timothy P CopelandDivision of Nephrology, Department of Medicine University of California-San Francisco, San Francisco, California.ORCID 0000-0002-3813-3576
Elaine KuDivision of Nephrology, Department of Medicine University of California-San Francisco, San Francisco, California.ORCID 0000-0002-7774-2526
Mark J SarnakDivision of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0003-1860-6302
Berenice GitomerDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0002-7457-6497
Kaleab Z AbebeDivision of General Internal Medicine, Department of Medicine, and Center for Biostatistics and Qualitative Methodology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Arlene ChapmanSection of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois.ORCID 0000-0002-6030-8694
Ronald PerroneDivision of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0002-4963-1132
Frederic F Rahbari-OskouiRenal Division, Department of Medicine Emory University, Atlanta, Georgia.ORCID 0000-0001-8933-4880
Theodore SteinmanDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Alan S L YuDivision of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.ORCID 0000-0002-1776-2533
Michel ChoncholDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Acute declines in kidney function during blood pressure interventions in CKDR01DK121904 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, ELAINE, SARNAK, MARK J · 2020 to 2023
$2.9M
Inspiratory muscle strength training for lowering systolic blood pressure in midlife and older adults with chronic kidney diseaseR01DK130266 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CHONCHOL, MICHEL BENJAMIN, NOWAK, KRISTEN LYNN · 2021 to 2025
$2.8M
Daily Caloric Restriction in Overweight and Obese Adults with ADPKDR01DK129259 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI NOWAK, KRISTEN LYNN · 2021 to 2025
$2.7M
Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and MechanismR01DK138915 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Petter Bjornstad, Kristen Lynn Nowak · 2024 to 2026
$2.0M
NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK121904NIDDK NIH HHS R01DK121904NIDDK NIH HHS R01 DK129259NIDDK NIH HHS R01 DK130266NIDDK NIH HHS R01DK130266NIDDK NIH HHS R01 DK138915
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADPKDclinical epidemiologycystic kidney diseaseESKDobesity

Identifiers

PMID39970002
PMCPMC12007826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.